status quo of quo vadis? - KCE

More documents

Recommendations

Info

128 Quality development in general practice in Belgium: status quo or quo vadis ? KCE Reports 76 Standard 5.3 - Clinical support processes CRITERION 5.3.1 SCHEDULE 8 MEDICINES 1. Schedule medicines stored in our practice are securely stored (direct observation). 2. The acquisition, storage, use, transfer and disposal of Schedule medicines in our practice is appropriately documented (document review). CRITERION 5.3.2 VACCINE POTENCY 1. our practice can demonstrate how our practice's cold chain management processes meet the current published edition of the NHMRC guidelines (direct observation). 2. our GP(s) and staff can describe how the process used for cold chain management meets the current published edition of the NHMRC guidelines (interview). 3. our practice has a documented policy for cold chain management procedures in accordance with the current published edition of the NHMRC guidelines (document review). CRITERION 5.3.3 PERISHABLE MATERIALS 1. our practice does not use or have medicines, vaccines or medical consumables beyond their expiry date in our practice or doctor's bag(s) (direct observation). 2. our relevant staff can describe the procedure for checking expiry dates of perishable materials and for disposing of such materials where necessary (interview). 3. our practice has a written procedure for checking expiry dates of perishable materials and for disposing of such materials where necessary (document review). CRITERION 5.3.4 INFECTION CONTROL 1. our GP(s) and staff can describe how our practice ensures that, where necessary, sterile equipment is used in clinical procedures (interview). 2. our GP(s) or staff members with designated responsibility can describe in detail how the use of sterile equipment is assured, including where relevant: • provision of an adequate range of disposable equipment • procedures for having instruments sterilised off-site • procedures for on-site sterilisation of equipment • monitoring the integrity and validation of the whole sterilisation process and steriliser maintenance • procedures for safe storage and stock rotation, and • education and training of staff involved (interview). 3. our GP(s) and staff can describe how risks of potential cross infection are managed within our practice, including procedures for: • hand hygiene • managing a sharps injury • safe storage and disposal of clinical waste including sharps • managing blood and body fluid spills • monitoring ongoing adherence to these processes (interview).
KCE Reports 76 Quality development in general practice in Belgium: status quo or quo vadis ? 129 4. our GP(s) and staff can describe: • the routine used by our practice for cleaning, disinfecting and decontaminating the clinical and non-clinical areas of our practice • standard precautions • additional precautions (interview). 5. our practice has a written policy that outlines our practice's infection control procedures (document review). 6. Subject to their informed consent, the immunisation status of our staff is known and staff members are offered immunisation appropriate to their duties (document review, interview). The induction of new staff to our practice ensures they are familiar with standard precautions against infection and other issues appropriate to their duties (document review, interview). APPENDIX 9: GP WORKFORCE IN BELGIUM These data come from the RIZIV/INAMI upon request in June 2007. The 002 and 003 are GPs without accreditation. The 003 and 004 are GPs with accreditation. The 002 and 004 hold a certificate for reimbursement of electrocardiography.
Page 1 and 2:
Kwaliteitsbevordering in de huisart
Page 3 and 4:
Kwaliteitsbevordering in de huisart
Page 5:
Hoe refereren naar dit document? Re
Page 8 and 9:
ii Kwaliteitsbevordering in de huis
Page 10 and 11:
iv Kwaliteitsbevordering in de huis
Page 12 and 13:
vi Kwaliteitsbevordering in de huis
Page 15 and 16:
KCE Reports 76 Quality development
Page 17 and 18:
Page 19 and 20:
Page 21 and 22:
Page 23 and 24:
Page 25 and 26:
Page 27 and 28:
Page 29 and 30:
Page 31 and 32:
Page 33 and 34:
Page 35 and 36:
21 Quality development in general p
Page 37 and 38:
Page 39 and 40:
Page 41 and 42:
Page 43 and 44:
Page 45 and 46:
Page 47 and 48:
Page 49 and 50:
Page 51 and 52:
Page 53 and 54:
KCE Reports Quality development in
Page 55 and 56:
Page 57 and 58:
Page 59 and 60:
Page 61 and 62:
Page 63 and 64:
Page 65 and 66:
Page 67 and 68:
Page 69 and 70:
Page 71 and 72:
Page 73 and 74:
Page 75 and 76:
Page 77 and 78:
Page 79 and 80:
Page 81 and 82:
Page 83 and 84:
Page 85 and 86:
Page 87 and 88:
Page 89 and 90:
Page 91 and 92: KCE Reports 76 Quality development
Page 141: KCE Reports 76 Quality development
Page 149 and 150: Health policy KCE Reports 76 Qualit
Page 151: KCE Reports 76 Quality development
Page 154 and 155: Wettelijk depot : D/2008/10.273/18
Page 156 and 157: 38. Baarmoederhalskankerscreening e
show all

status quo of quo vadis? - KCE

Create successful ePaper yourself

Delete template?

Save as template?